Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors

References

• Bell IM. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? J Med Chem 2004;47:1869–1878.
   PubMed Web of Science ®Google Scholar
• Hancock JF, Magee AI, Childs JE, Marshall CJ. All Ras proteins are polyisoprenylated but only some are palmitoylated. Cell 1989;57:1167–1177.
   PubMed Web of Science ®Google Scholar
• Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ. Farnesyl modification of Kirsten-Ras Exon 4B protein is essential for transformation. Proc Natl Acad Sci USA 1990;87:3042–3046.
   PubMed Web of Science ®Google Scholar
• Bell IM. Inhibitors of protein prenylation 2000. Expert Opin Ther Patents 2000;10:1813–1831.
   Web of Science ®Google Scholar
• Tanaka R, Rubio A, Harn NK, Gernert D, Grese TA, Eishima J et al. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential. Bioorg Med Chem 2007;15:1363–1382.
   Google Scholar
• Ganguly AK, Doll RJ, Girijavallabhan VM. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336. Curr Med Chem 2001;8:1419–1436.
   PubMed Web of Science ®Google Scholar
• Equbal T, Silakari O, Rambabu G, Ravikumar M. Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors. Bioorg Med Chem Lett 2007;17:1594–1600.
   PubMed Web of Science ®Google Scholar
• Venet M, End D, Angibaud P. Farnesyl protein transferase inhibitor ZARNESTRA R115777 - history of a discovery. Curr Top Med Chem 2003;3:1095–1102.
   PubMed Web of Science ®Google Scholar
• Buckner FS, Yokoyama K, Nguyen L, Grewal A, Erdjument-Bromage H, Tempst P et al. Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei. J Biol Chem 2000;275:21870–21876.
   Google Scholar
• Ohkanda J, Buckner FS, Lockman JW, Yokoyama K, Carrico D, Eastman R et al. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. J Med Chem 2004;47:432–445.
   PubMed Web of Science ®Google Scholar
• Nguyen UT, Cramer J, Gomis J, Reents R, Gutierrez-Rodriguez M, Goody RS et al. Exploiting the substrate tolerance of farnesyltransferase for site-selective protein derivatization. Chembiochem 2007;8:408–423.
   PubMed Web of Science ®Google Scholar
• Basso AD, Kirschmeier P, Bishop WR. Lipid posttranslational modifications. Farnesyl transferase inhibitors. J Lipid Res 2006;47:15–31.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. Curr Med Chem 2008;15:1478–1492.
   PubMed Web of Science ®Google Scholar
• Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci 2007;26:694–701.
   Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Farnesyltransferase: theoretical studies on peptide substrate entrance—thiol or thiolate coordination? J Mol Struct (Theochem) 2005;729:125–129.
   Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Farnesyltransferase—new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism. Biophys J 2005;88:483–494.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Theoretical studies on farnesyltransferase: the distances paradox explained. Proteins 2007;66:205–218.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Theoretical studies on farnesyl transferase: evidence for thioether product coordination to the active-site zinc sphere. J Comput Chem 2007;28:1160–1168.
   PubMed Web of Science ®Google Scholar
• Park HW, Boduluri SR, Moomaw JF, Casey PJ, Beese LS. Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution. Science 1997;275:1800–1804.
   PubMed Web of Science ®Google Scholar
• Long SB, Casey PJ, Beese LS. Reaction path of protein farnesyltransferase at atomic resolution. Nature 2002;419:645–650.
   PubMed Web of Science ®Google Scholar
• Long SB, Hancock PJ, Kral AM, Hellinga HW, Beese LS. The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics. Proc Natl Acad Sci USA 2001;98:12948–12953.
   PubMed Web of Science ®Google Scholar
• Tobin DA, Pickett JS, Hartman HL, Fierke CA, Penner-Hahn JE. Structural characterization of the zinc site in protein farnesyltransferase. J Am Chem Soc 2003;125:9962–9969.
   PubMed Web of Science ®Google Scholar
• Pompliano DL, Rands E, Schaber MD, Mosser SD, Anthony NJ, Gibbs JB. Steady-state kinetic mechanism of Ras farnesyl:protein transferase. Biochemistry 1992;31:3800–3807.
   PubMed Web of Science ®Google Scholar
• Furfine ES, Leban JJ, Landavazo A, Moomaw JF, Casey PJ. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release. Biochemistry 1995;34:6857–6862.
   Google Scholar
• Fu HW, Beese LS, Casey PJ. Kinetic analysis of zinc ligand mutants of mammalian protein farnesyltransferase. Biochemistry 1998;37:4465–4472.
   Google Scholar
• Hightower KE, De S, Weinbaum C, Spence RA, Casey PJ. Lysine(164)alpha of protein farnesyltransferase is important for both CaaX substrate binding and catalysis. Biochem J 2001;360:625–631.
   Google Scholar
• Pickett JS, Bowers KE, Hartman HL, Fu HW, Embry AC, Casey PJ et al. Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. Biochemistry 2003;42:9741–9748.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Enzyme flexibility and the catalytic mechanism of farnesyltransferase: targeting the relation. J Phys Chem B 2008;112:8681–8691.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Molecular dynamics analysis of farnesyltransferase: a closer look into the amino acid behavior. Int J Quant Chem 2008;108:1939–1950.
   Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme. Bioorg Med Chem 2009;17:3369–3378.
   PubMed Web of Science ®Google Scholar
• Sousa SF, Fernandes PA, Ramos MJ. The search for the mechanism of the reaction catalyzed by farnesyltransferase. Chemistry 2009;15:4243–4247.
   Google Scholar
• Ho MH, De Vivo M, Dal Peraro M, Klein ML. Unraveling the catalytic pathway of metalloenzyme farnesyltransferase through QM/MM computation. J Chem Theor Comput 2009;5:1657–1666.
   PubMedGoogle Scholar
• Rida SM, El-Hawash SA, Fahmy HT, Hazzaa AA, El-Meligy MM. Synthesis of novel benzofuran and related benzimidazole derivatives for evaluation of in vitro anti-HIV-1, anticancer and antimicrobial activities. Arch Pharm Res 2006;29:826–833.
   PubMed Web of Science ®Google Scholar
• Galal SA, Abd El-All AS, Abdallah MM, El-Diwani HI. Synthesis of potent antitumor and antiviral benzofuran derivatives. Bioorg Med Chem Lett 2009;19:2420–2428.
   PubMed Web of Science ®Google Scholar
• Thai KM, Ecker GF. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers. Mol Divers 2009;13:321–336.
   PubMed Web of Science ®Google Scholar
• Labute P. A widely applicable set of descriptors. J Mol Graph Model 2000;18:464–477.
   PubMed Web of Science ®Google Scholar
• Balaji S, Karthikeyan C, Moorthy NSHN, Trivedi P. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors. Bioorg Med Chem Lett 2004;14:6089–6094.
   PubMed Web of Science ®Google Scholar
• Asoh K, Kohchi M, Hyoudoh I, Ohtsuka T, Masubuchi M, Kawasaki K et al. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorg Med Chem Lett 2009;19:1753–1757.
   PubMedGoogle Scholar
• Molecular Operating Environment (MOE). Chemical Computing Group Inc. Montreal, H3A 2R7 Canada, 2007.
   Google Scholar
• Systatica. (8.0). StatSoft Inc. Tulsa, OK, USA, 2008.
   Google Scholar
• Lin A. QuaSAR-descriptors. Chemical Computing Group Inc. Montreal, H3A 2R7 Canada, 2002.
   Google Scholar
• Baurin N, Mozziconacci JC, Arnoult E, Chavatte P, Marot C, Morin-Allory L. 2D QSAR consensus prediction for high-throughput virtual screening. An application to COX-2 inhibition modeling and screening of the NCI database. J Chem Inf Comput Sci 2004;44:276–285.
   PubMedGoogle Scholar
• Golbraikh A, Tropsha A. Beware of Q2! J Mol Graph Model 2002;20:269–276.
   PubMed Web of Science ®Google Scholar
• Eriksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect 2003;111:1361–1375.
   PubMed Web of Science ®Google Scholar
• Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 2003;22:69–77.
   Google Scholar
• Roy PP, Roy K. On some aspectes of variable selected for partial least squares regression models. QSAR Comb Sci 2008;27:302–313.
   Google Scholar
• Pratim Roy P, Paul S, Mitra I, Roy K. On two novel parameters for validation of predictive QSAR models. Molecules 2009;14:1660–1701.
   PubMed Web of Science ®Google Scholar
• Cook RD. Influential observations in linear-regression. J Am Stat Assoc 1979;74:169–174.
   Web of Science ®Google Scholar
• Vilar S, González-Díaz H, Santana L, Uriarte E. QSAR model for alignment-free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HP-lattice networks. J Comput Chem 2008;29:2613–2622.
   Google Scholar
• Gnanades R, Kettenri JR. Robust estimates, residuals, and outlier detection with multiresponse data. Biometrics 1972;28:81–124.
   Google Scholar
• O’Brien RM. A caution regarding rules of thumb for variance inflation factors. Qual Quant 2007;41:673–690.
   Web of Science ®Google Scholar
• Neter J, Wasserman W, Kunter MH. Applied linear statistical models: regression, analysis of variance, and experimental designs. 3rd ed. Homewood (IL): Irwin, 1990.
   Google Scholar
• Gujarati DN. Qualitative response regression models. In: Basic Econometrics, 4th ed. Boston: McGraw-Hill, 2003.
   Google Scholar
• Prasanna S, Manivannan E, Chaturvedi SC. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands. Bioorg Med Chem Lett 2005;15:2097–2102.
   PubMed Web of Science ®Google Scholar
• Durbin J, Watson GS. Testing for serial correlation in least squares regression. I. Biometrika 1950;37:409–428.
   PubMed Web of Science ®Google Scholar
• Durbin J, Watson GS. Testing for serial correlation in least squares regression. II. Biometrika 1951;38:159–178.
   PubMed Web of Science ®Google Scholar
• Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci 1999;39:868–873.
   Google Scholar
• Mulliken RS. A new electroaffinity scale; together with data on valence states and on valence ionization potentials and electron affinities. J Chem Phys 1934;2:782–793.
   Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity—A rapid access to atomic charges. Tetrahedron 1980;36:3219–3228.
   Web of Science ®Google Scholar
• Tamames B, Sousa SF, Tamames J, Fernandes PA, Ramos MJ. Analysis of zinc-ligand bond lengths in metalloproteins: trends and patterns. Proteins 2007;69:466–475.
   PubMed Web of Science ®Google Scholar
• Long SB, Casey PJ, Beese LS. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. Biochemistry 1998;37:9612–9618.
   PubMed Web of Science ®Google Scholar
• Strickland CL, Windsor WT, Syto R, Wang L, Bond R, Wu Z et al. Crystal structure of farnesyl protein transferase complexed with a CaaX peptide and farnesyl diphosphate analogue. Biochemistry 1998;37:16601–16611.
   PubMed Web of Science ®Google Scholar
• Kral AM, Diehl RE, deSolms SJ, Williams TM, Kohl NE, Omer CA. Mutational analysis of conserved residues of the beta-subunit of human farnesyl:protein transferase. J Biol Chem 1997;272:27319–27323.
   PubMedGoogle Scholar
• Hightower KE, Casey PJ, Fierke CA. Farnesylation of nonpeptidic thiol compounds by protein farnesyltransferase. Biochemistry 2001;40:1002–1010.
   PubMedGoogle Scholar
• Dunten P, Kammlott U, Crowther R, Weber D, Palermo R, Birktoft J. Protein farnesyltransferase: structure and implications for substrate binding. Biochemistry 1998;37:7907–7912.
   PubMed Web of Science ®Google Scholar
• Gao H. Application of BCUT metrics and genetic algorithm in binary QSAR analysis. J Chem Inf Comput Sci 2001;41:402–407.
   Google Scholar
• González MP, Terán C, Teijeira M, Besada P, González-Moa MJ. BCUT descriptors to predicting affinity toward A3 adenosine receptors. Bioorg Med Chem Lett 2005;15:3491–3495.
   Google Scholar